TRU-015 Terminated Phase 1 Trials for B Cell Lymphoma (BCL) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00521638Study Evaluating TRU-015 in B-Cell Non-Hodgkin's Lymphoma